Catalyst Watch: Apple event, Oracle earnings, and Klarna leads an IPO blitz
Source: SeekingAlpha
2025-09-05 15:00:47 ET
More on the markets
- U.S. Job Worries Intensify Calls For Immediate Fed Rate Cuts
- Tariffs Are Taxes: Ergo, Tax Cuts Are Coming
- Jobs Shock: 22K Hires, 4.3% Unemployment -- 50 Bps Is Now On The Table
- September Fed cut largely fully priced in after jobs report
- Hyperscaler capex helps AI boom, but some risks remain, Goldman Sach says
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Apple event, Oracle earnings, and Klarna leads an IPO blitz
IDEAYA Biosciences Inc.
NASDAQ: IDYA
IDYA Trading
-1.52% G/L:
$32.48 Last:
170,945 Volume:
$33.22 Open:
IDYA Latest News
March 09, 2026 06:00:00 am
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update
February 25, 2026 06:00:00 am
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 23, 2026 06:00:00 am
IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer
IDYA Stock Data
$2,916,661,394
85,474,748
1.71%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
